L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm

British Journal of Haematology

Volumn 163, Issue 4, 2013, Pages 543-545

  Gruson, Bérengère ^a   Vaida, Ioana ^a   Merlusca, Lavinia ^a   Charbonnier, Amandine ^a   Parcelier, Anne ^a   Damaj, Gandhi ^a   Royer, Bruno ^a   Marolleau, Jean Pierre ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Blastic plasmacytoid dendritic cell neoplasm; L asparaginase; Methotrexate; Plasmacytoid dendritic cell

Indexed keywords

ACLOTINE; ANTITHROMBIN; ASPARAGINASE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ERWINIA ASPARAGINASE; ERWINIASE; FIBRINOGEN; FOLINIC ACID; METHOTREXATE; PREDNISOLONE; UNCLASSIFIED DRUG; VALACICLOVIR; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANDIDIASIS; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FIBRINOGEN BLOOD LEVEL; GASTRITIS; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; LUNG DISEASE; LUNG EMBOLISM; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREATITIS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TREATMENT DURATION;

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; L-ASPARAGINASE; METHOTREXATE; PLASMACYTOID DENDRITIC CELL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BONE MARROW NEOPLASMS; DENDRITIC CELLS; DEXAMETHASONE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84886391710     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12523     Document Type: Letter

References (10)

1. Chaperot, L., Bendriss, N., Manches, O., Gressin, R., Maynadie, M., Trimoreau, F., Orfeuvre, H., Corront, B., Feuillard, J., Sotto, J.J., Bensa, J.C., Brière, F., Plumas, J. & Jacob, M.C. (2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood, 97, 3210-3217.
2. Dalle, S., Beylot-Barry, M., Bagot, M., Lipsker, D., Machet, L., Joly, P., Dompmartin, A., d'Incan, M., Maubec, E., Grange, F., Dereure, O., Prey, S., Barete, S., Wetterwald, M., Fraitag, S. & Petrella, T. (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? The British Journal of Dermatology, 162, 74-79.
3. Dijkman, R., van Doorn, R., Szuhai, K., Willemze, R., Vermeer, M.H. & Tensen, C.P. (2007) Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood, 109, 1720-1727.
4. Fontaine, J., Thomas, L., Balme, B., Ronger-Savle, S., Traullé, C., Petrella, T. & Dalle, S. (2009) Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment. Clinical and Experimental Dermatology, 34, e43-e45.
5. Garnache-Ottou, F., Feuillard, J., Ferrand, C., Biichle, S., Trimoreau, F., Seilles, E., Salaun, V., Garand, R., Lepelley, P., Maynadié, M., Kuhlein, E., Deconinck, E., Daliphard, S., Chaperot, L., Beseggio, L., Foisseaud, V., Macintyre, E., Bene, M.C., Saas, P. & Jacob, M.C.; GOELAMS and and GEIL study. (2009) Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. British Journal of Haematology, 145, 624-636.
6. Gilis, L., Lebras, L., Bouafia-Sauvy, F., Espinouse, D., Felman, P., Berger, F., Salles, G., Coiffier, B. & Michallet, A.S. (2012) Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm. Leukemia and Lymphoma, 53, 1633-1637.
7. Jardin, F., Callanan, M., Penther, D., Ruminy, P., Troussard, X., Kerckaert, J.P., Figeac, M., Parmentier, F., Rainville, V., Vaida, I., Bertrand, P., Duval, A.B., Picquenot, J.M., Chaperot, L., Marolleau, J.P., Plumas, J., Tilly, H. & Bastard, C. (2009) Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia, 23, 698-707.
8. Pagano, L., Valentini, C.G., Pulsoni, A., Fisogni, S., Carluccio, P., Mannelli, F., Lunghi, M., Pica, G., Onida, F., Cattaneo, C., Piccaluga, P.P., Di Bona, E., Todisco, E., Musto, P., Spadea, A., D'Arco, A., Pileri, S., Leone, G., Amadori, S. & Facchetti, F.; GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell'Adulto, Acute Leukemia Working Party). (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica, 98, 239-246.
9. Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D.W., Cornelissen, J.J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M. & Dreger, P.; European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. (2013) Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood, 121, 440-446.
10. Tsagarakis, N.J., Kentrou, N.A., Papadimitriou, K.A., Pagoni, M., Kokkini, G., Papadaki, H., Pappa, V., Marinakis, T., Anagnostopoulos, N.I., Vadikolia, C., Anagnostopoulos, A., Angelopoulou, M.K., Terpos, E., Poziopoulos, C., Anargyrou, K., Rontogianni, D., Papadaki, T., Psarra, A., Kontopidou, F.N., Skoumi, D., Papadhimitriou, S.I. & Paterakis, G.; Hellenic Dendritic Cell Leukemia Study Group. (2010) Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leukemia Research, 34, 438-446.